Distinguishing between food allergies and intolerances is crucial.
April 2025
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the April, 2025, issue of Contemporary Pediatrics, with a special focus on pediatric allergy awareness.
Flovent was discontinued in January 2024 due to the manufacturer electing to produce only an authorized generic version of the medication.
The newly-approved indication is for children aged 4 years and older who weigh 33 < 66 lbs, expanding on the August 9, 2024 approval in children at least 66 lbs.
On exam, the patient is found to have circular, slightly raised, blanching, erythematous papules on the lower extremities and abdomen.
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally.
Higher physical activity and lower screen time in childhood were linked to reduced stress and depression in adolescence, according to a Finnish cohort study.
In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome
3
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
4
Vaccines in childhood linked to lower drug-resistant bacteria risk
5
